| Share Name |
Share Symbol |
Market |
Type |
Share ISIN |
Share Description |
| Instem Plc |
LSE:INS |
London |
Ordinary Share |
GB00B3TQCK30 |
ORD 10P |
| |
Price Change |
% Change |
Share Price |
Bid Price |
Offer Price |
High Price |
Low Price |
Open Price |
Shares Traded |
Last Trade |
| |
7.50 |
0.84% |
900.00 |
890.00 |
910.00 |
902.50 |
900.00 |
900.00 |
3,572 |
09:38:56 |
| Industry Sector |
Turnover (m) |
Profit (m) |
EPS - Basic |
PE Ratio |
Market Cap (m) |
| Software & Computer Services |
25.7 |
-0.9 |
-5.7 |
- |
200 |
Instem Share Discussion Threads
Showing 1051 to 1073 of 1075 messages
| Date | Subject | Author | Discuss |
|---|
27/9/2021
07:11 | Results, keeps chugging along.
Integration of acquisitions etc.
GLA. | 
p1nkfish | |
03/9/2021
20:44 | good deal of consolidation going on in drug development software, INS having acquired the smaller Swiss competitor and Certara having acquired Pinnacle 21 in the USA. | 
mw8156 | |
01/9/2021
16:37 | Indeed, just let it climb under cover. |
p1nkfish | |
10/8/2021
20:59 | Not annoyed.
Perhaps I'm just a good guesser! Nod, nod, wink, wink. |
p1nkfish | |
10/8/2021
20:22 | Close to ATHs - some of those spikes up are rogue UTs. Any break up and I'll be adding again | 
davr0s | |
10/8/2021
17:03 | Ticked up after your post just to annoy you? |
davr0s | |
10/8/2021
15:10 | Been a good ride, GLA.
Patience rewarded. |
p1nkfish | |
09/6/2021
20:22 | Who knows, but there was a lot of volume today |
davr0s | |
09/6/2021
20:05 | News tomorrow, something leaked? | 
lomax99 | |
24/5/2021
17:15 | https://www.dailymail.co.uk/money/investing/article-9613361/SMALL-CAP-SHARE-IDEAS-Instem.html | 
pugugly | |
12/4/2021
08:45 | Small top up for me, still a buy in Techinvest following d-wise acquisition. |
lomax99 | |
12/4/2021
07:58 | Usual excellent delivery from Instem in their annual results today. Presentation on InvestorMeetCompany later this afternoon. | 
tradertrev | |
06/4/2021
07:02 | Wonder how long before the likes of EVOTEC take an interest. I was a shareholder of Cyprotex when they bought them. Instem could very well be of interest and on the list & they could afford £200M+. |
p1nkfish | |
30/3/2021
16:06 | Missed the call. Will watch later or tomorrow. Was it ok? |
p1nkfish | |
30/3/2021
15:56 | I don't think there are any in the UK, not listed anyway. Phil Reason mentioned a company called Cetara which is NASDAQ listed. They have a $3.9bn mkt cap which is 14x their projected 2021 sales. Instem mkt cap of £133m is 2.7x 2021E revenue. EV/EBITDA Cetara is 38.2x whereas INS is 14.4x.
Their products are more complements than substitutes even though they operate in the same field and obviously you would expect NASDAQ companies to be rated more highly because, er, well, they just are! | 
jombaston | |
23/3/2021
12:27 | seems they now have an end-to-end capability from drug discovery to drug surveillance once marketed, so if they can integrate the acquisitions successfully the company should be well-set to grow. Does anyone else have the same capability? |
mw8156 | |
22/3/2021
08:20 | Looks a nice deal - only paying 10x pre-tax profit. |
tradertrev | |
15/3/2021
22:41 | buy price 577 sell price 580 this morning albeit for only 500 shares...market maker short of stock? |
mw8156 | |
01/3/2021
19:09 | At last, we've spent some money - and reasonably wisely too by the looks of it. |
tradertrev | |
04/1/2021
15:43 | Hopefully! Been a long time coming. |
tradertrev | |
04/1/2021
14:37 | Finally creeping up, acquisition news soon? |
lomax99 | |
15/12/2020
07:54 | Great news, I had wondered why we saw some share price strength yesterday. |
lomax99 | |
15/12/2020
07:45 | Excellent news, bet a very decent amount falls to the bottom line. |
p1nkfish | |
PLUS1
